Milim Kim

629 total citations
26 papers, 386 citations indexed

About

Milim Kim is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Milim Kim has authored 26 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Milim Kim's work include Cancer Immunotherapy and Biomarkers (6 papers), Breast Cancer Treatment Studies (4 papers) and Immunotherapy and Immune Responses (4 papers). Milim Kim is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Breast Cancer Treatment Studies (4 papers) and Immunotherapy and Immune Responses (4 papers). Milim Kim collaborates with scholars based in South Korea, Puerto Rico and Ethiopia. Milim Kim's co-authors include So Yeon Park, Yul Ri Chung, Hyun Jeong Kim, Ji Won Woo, Min Hye Jang, Jae Moon Gwak, Soomin Ahn, Eun‐Kyu Kim, Eunyoung Kang and Hye Yeon Choi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Milim Kim

25 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Milim Kim South Korea 11 183 125 94 77 77 26 386
Ehab Husain United Kingdom 11 135 0.7× 129 1.0× 118 1.3× 51 0.7× 33 0.4× 25 398
Miki Yamaguchi Japan 13 184 1.0× 88 0.7× 76 0.8× 53 0.7× 53 0.7× 33 436
Hailong Chen China 12 112 0.6× 246 2.0× 185 2.0× 84 1.1× 49 0.6× 22 466
B. Szynglarewicz Poland 11 225 1.2× 132 1.1× 67 0.7× 80 1.0× 31 0.4× 52 407
David Chung Australia 12 187 1.0× 106 0.8× 61 0.6× 76 1.0× 80 1.0× 40 405
Yanjun Hou United States 12 269 1.5× 123 1.0× 62 0.7× 48 0.6× 135 1.8× 29 442
Zhimin Shao China 12 112 0.6× 187 1.5× 100 1.1× 94 1.2× 62 0.8× 23 362
Bernard Ho Singapore 9 179 1.0× 102 0.8× 48 0.5× 188 2.4× 28 0.4× 28 373
Gang Cai China 15 183 1.0× 225 1.8× 105 1.1× 109 1.4× 91 1.2× 47 524

Countries citing papers authored by Milim Kim

Since Specialization
Citations

This map shows the geographic impact of Milim Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milim Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milim Kim more than expected).

Fields of papers citing papers by Milim Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milim Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milim Kim. The network helps show where Milim Kim may publish in the future.

Co-authorship network of co-authors of Milim Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Milim Kim. A scholar is included among the top collaborators of Milim Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milim Kim. Milim Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Hyung Kyung, Kwangil Yim, Jamshid Abdul‐Ghafar, et al.. (2024). Artificial-Intelligence-Assisted Detection of Metastatic Colorectal Cancer Cells in Ascitic Fluid. Cancers. 16(5). 1064–1064. 10 indexed citations
2.
Park, Jae Hyon, Milim Kim, Insun Park, et al.. (2024). Tumor necrosis in magnetic resonance imaging predicts urothelial carcinoma with squamous differentiation in muscle-invasive bladder carcinoma. Abdominal Radiology. 49(12). 4341–4351. 1 indexed citations
3.
Kim, Milim, Yujun Park, Hyun Jung Kwon, et al.. (2024). Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status. Breast Cancer. 31(4). 705–716. 5 indexed citations
4.
Kim, Milim, et al.. (2023). Occupancy-Based Energy Consumption Estimation Improvement through Deep Learning. Sensors. 23(4). 2127–2127. 7 indexed citations
5.
Kim, Milim, et al.. (2023). Application of Small Cell Lung Cancer Molecular Subtyping Markers to Small Cell Neuroendocrine Carcinoma of the Cervix. The American Journal of Surgical Pathology. 48(3). 364–372. 8 indexed citations
6.
Kim, Se Hyun, Seock‐Ah Im, Koung Jin Suh, et al.. (2023). Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16). European Journal of Cancer. 195. 113386–113386. 7 indexed citations
7.
Han, Song‐Hee, Milim Kim, Yul Ri Chung, et al.. (2022). Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer. Scientific Reports. 12(1). 20367–20367. 12 indexed citations
8.
Kim, Young‐Gon, In Hye Song, Sungchul Kim, et al.. (2022). Diagnostic Assessment of Deep Learning Algorithms for Frozen Tissue Section Analysis in Women with Breast Cancer. Cancer Research and Treatment. 55(2). 513–522. 2 indexed citations
9.
Woo, Ji Won, Hye Yeon Choi, Milim Kim, Yul Ri Chung, & So Yeon Park. (2022). miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast. Breast Cancer. 29(5). 814–824. 3 indexed citations
10.
Kim, Milim, Hye Yeon Choi, Ji Won Woo, Yul Ri Chung, & So Yeon Park. (2021). Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast. Scientific Reports. 11(1). 18007–18007. 24 indexed citations
11.
Kim, Milim, Yul Ri Chung, Hyun Jeong Kim, et al.. (2020). Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast. Breast Cancer Research. 22(1). 32–32. 36 indexed citations
12.
Ahn, Soomin, Yul Ri Chung, An Na Seo, et al.. (2020). Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer. PLoS ONE. 15(5). e0233037–e0233037. 15 indexed citations
13.
Woo, Ji Won, Yul Ri Chung, Milim Kim, et al.. (2020). Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers. Cancer Immunology Immunotherapy. 70(5). 1365–1378. 6 indexed citations
15.
Chung, Yul Ri, Hyun Jeong Kim, Milim Kim, Soomin Ahn, & So Yeon Park. (2018). Clinical implications of changes in the diversity of c-MYC copy number variation after neoadjuvant chemotherapy in breast cancer. Scientific Reports. 8(1). 16668–16668. 5 indexed citations
16.
Ahn, Soomin, Hyun Jeong Kim, Milim Kim, et al.. (2018). Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer. Cancer Research and Treatment. 50(4). 1418–1432. 20 indexed citations
17.
Kim, Milim, Hyun Jeong Kim, Yul Ri Chung, et al.. (2018). Microinvasive Carcinoma versus Ductal CarcinomaIn Situ: A Comparison of Clinicopathological Features and Clinical Outcomes. Journal of Breast Cancer. 21(2). 197–197. 44 indexed citations
18.
Kim, Milim, et al.. (2017). A study on entertainment TV show ratings and the number of episodes prediction. Korean Journal of Applied Statistics. 30(6). 809–825. 1 indexed citations
19.
Gwak, Jae Moon, Milim Kim, Hyun Jeong Kim, Min Hye Jang, & So Yeon Park. (2017). Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance. Oncotarget. 8(22). 36305–36318. 65 indexed citations
20.
Kim, Mimi, Milim Kim, Yul Ri Chung, & So Yeon Park. (2017). Mammary Carcinoma Arising in Microglandular Adenosis: A Report of Five Cases. Journal of Pathology and Translational Medicine. 51(4). 422–427. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026